[Neuroleptics, atypical antipsychotics and "awakening"].
Clinical response to the treatment of schizophrenic patients with atypical antipsychotics is sometimes labeled as "awakening". However, there is no general agreement what this term specifically means. The wide range of definitions starts from withdrawal of side effects of classical neuroleptics and goes through psychological phenomena to the definition that postulates arresting of the psychotic process. The paper presents a review of different points of view on "awakening" phenomena as well as problems that are connected with it. Some own experiences and attempts at generalization are presented. They deal with new problems and challenges connected with treatment of patients with acute and chronic schizophrenia with atypical antipsychotics.
Murawiec
S
S
III Kliniki Psychiatrycznej IPiN w Warszawie.
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001364:Awareness / Q000187:drug effects*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents
Neuroleptyki, atypowe leki antypsychotyczne i "przebudzenie".